These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12140752)

  • 61. [HL-A antigens as genetic determinants of disease].
    Pietrzyk JJ; Turowski G
    Pol Arch Med Wewn; 1976 May; 55(5):487-97. PubMed ID: 775458
    [No Abstract]   [Full Text] [Related]  

  • 62. [The current concepts of the etiology and pathogenesis of autoimmune endocrinopathies].
    Luk'ianchikov VS; Kalinin AP; Luk'ianchikov VV
    Ter Arkh; 1995; 67(10):3-6. PubMed ID: 8779099
    [No Abstract]   [Full Text] [Related]  

  • 63. Association between HLA and diseases: an overview.
    Duquesnoy RJ
    Cutis; 1980 Feb; 25(2):120, 122, 125 passim. PubMed ID: 7357878
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of splice-site polymorphisms of the TMPRSS4, NPHP4 and ORCTL4 genes on their mRNA expression.
    Yamada H; Shinmura K; Tsuneyoshi T; Sugimura H
    J Genet; 2005 Aug; 84(2):131-6. PubMed ID: 16131712
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic Factors of Autoimmune Diseases 2017.
    Ceccarelli F; Agmon-Levin N; Perricone C
    J Immunol Res; 2017; 2017():2789242. PubMed ID: 29270439
    [No Abstract]   [Full Text] [Related]  

  • 66. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene.
    Davison LJ; Wallace C; Cooper JD; Cope NF; Wilson NK; Smyth DJ; Howson JM; Saleh N; Al-Jeffery A; Angus KL; Stevens HE; Nutland S; Duley S; Coulson RM; Walker NM; Burren OS; Rice CM; Cambien F; Zeller T; Munzel T; Lackner K; Blakenberg S; ; Fraser P; Gottgens B; Todd JA; Attwood T; Belz S; Braund P; Cambien F; Cooper J; Crisp-Hihn A; Diemert P; Deloukas P; Foad N; Erdmann J; Goodall AH; Gracey J; Gray E; Williams RG; Heimerl S; Hengstenberg C; Jolley J; Krishnan U; Lloyd-Jones H; Lugauer I; Lundmark P; Maouche S; Moore JS; Muir D; Murray E; Nelson CP; Neudert J; Niblett D; O'Leary K; Ouwehand WH; Pollard H; Rankin A; Rice CM; Sager H; Samani NJ; Sambrook J; Schmitz G; Scholz M; Schroeder L; Schunkert H; Syvannen AC; Tennstedt S; Wallace C
    Hum Mol Genet; 2012 Jan; 21(2):322-33. PubMed ID: 21989056
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [HLA and renal diseases].
    Adorno D; Barnabei R; Irti T; Papola F; Piazza A; Spagnoli G; Valeri M
    Minerva Med; 1982 Feb; 73(6):269-72. PubMed ID: 6460205
    [No Abstract]   [Full Text] [Related]  

  • 68. Polymorphism of the CTLA1 gene on chromosome 14.
    Nguyen V; Haddad P; Cox DW
    Hum Mol Genet; 1992 Jul; 1(4):286. PubMed ID: 1363871
    [No Abstract]   [Full Text] [Related]  

  • 69. Genetic background and environment contribute synergistically to the onset of autoimmune diseases.
    Luppi P; Rossiello MR; Faas S; Trucco M
    J Mol Med (Berl); 1995 Aug; 73(8):381-93. PubMed ID: 8528740
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Some implications of transplantation research for biology and medicine.
    Hamburger J
    Transplant Proc; 1977 Mar; 9(1):1313-7. PubMed ID: 325752
    [No Abstract]   [Full Text] [Related]  

  • 71. Immunogenetic markers in autoimmune disease.
    Pandey JP; Fudenberg HH
    Ann Intern Med; 1984 Dec; 101(6):868-9. PubMed ID: 6594075
    [No Abstract]   [Full Text] [Related]  

  • 72. Decreased sensitivity to prostaglandin and histamine in lymphocytes from normal HLA-B12 individuals: a possible role in autoimmunity.
    Staszak C; Goodwin JS; Troup GM; Pathak DR; Williams RC
    J Immunol; 1980 Jul; 125(1):181-5. PubMed ID: 7381200
    [No Abstract]   [Full Text] [Related]  

  • 73. HLA 2000.
    Charron D
    Vox Sang; 2000; 78 Suppl 2():27-8. PubMed ID: 10938922
    [No Abstract]   [Full Text] [Related]  

  • 74. Synthetic gene frequency maps of man and selective effects of climate.
    Piazza A; Menozzi P; Cavalli-Sforza LL
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2638-42. PubMed ID: 6941316
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Biological functions of HL-A area genes--in relation to disease susceptibility].
    Kaneoka H; Sasazuki T
    Nihon Rinsho; 1978 Sep; 36(9):3096-101. PubMed ID: 364100
    [No Abstract]   [Full Text] [Related]  

  • 76. A novel actor in antitumoral immunity: The thymus-specific serine protease TSSP/PRSS16 involved in CD4
    Brisson L; Carrier A
    Oncoimmunology; 2015 Sep; 4(9):e1026536. PubMed ID: 26405595
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Marburg I polymorphism of factor VII-activating protease and risk of venous thromboembolism.
    Franchi F; Martinelli I; Biguzzi E; Bucciarelli P; Mannucci PM
    Blood; 2006 Feb; 107(4):1731. PubMed ID: 16461761
    [No Abstract]   [Full Text] [Related]  

  • 78. Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients.
    Hageman I; Mol F; Atiqi S; Joustra V; Sengul H; Henneman P; Visman I; Hakvoort T; Nurmohamed M; Wolbink G; Levin E; Li Yim AYF; D'Haens G; de Jonge WJ
    Front Immunol; 2023; 14():1303231. PubMed ID: 38187379
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes.
    Clark M; Kroger CJ; Ke Q; Tisch RM
    Front Immunol; 2020; 11():615371. PubMed ID: 33603744
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thymus-specific serine protease, a protease that shapes the CD4 T cell repertoire.
    Guerder S; Hassel C; Carrier A
    Immunogenetics; 2019 Mar; 71(3):223-232. PubMed ID: 30225612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.